Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis

A high incidence of pancreatitis in COVID-19 has been reported. Although a high proportion of critically unwell patients with COVID-19 have raised serum amylase levels, this does not necessarily reflect acute pancreatitis or a clinically important pancreatic injury.

Automated summary

A high incidence of pancreatitis has been reported in COVID-19 patients, but elevated serum amylase levels in critically ill patients do not necessarily indicate acute pancreatitis or clinically significant pancreatic injury.